CCDC121 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.827500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.701400E-01
Normal-vs-Stage2
9.056300E-03
Normal-vs-Stage3
1.553700E-02
Normal-vs-Stage4
8.684800E-01
Stage1-vs-Stage2
2.484000E-02
Stage1-vs-Stage3
6.609900E-02
Stage1-vs-Stage4
4.314600E-01
Stage2-vs-Stage3
3.150200E-01
Stage2-vs-Stage4
1.528160E-01
Stage3-vs-Stage4
6.300300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.689600E-02
Normal-vs-AfricanAmerican
2.663900E-02
Normal-vs-Asian
1.799730E-02
Caucasian-vs-AfricanAmerican
9.011000E-01
Caucasian-vs-Asian
3.962000E-01
AfricanAmerican-vs-Asian
4.078800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.382260E-02
Normal-vs-Female
1.297760E-01
Male-vs-Female
1.112190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.029830E-01
Normal-vs-Age(41-60Yrs)
5.696200E-02
Normal-vs-Age(61-80Yrs)
6.252200E-02
Normal-vs-Age(81-100Yrs)
4.037800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.320200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.270600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.495370E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.371400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.169900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.681200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.951800E-04
Normal-vs-Daily Drinker
2.757300E-03
Normal-vs-Weekly Drinker
4.115600E-02
Normal-vs-Occasional Drinker
5.692800E-01
Normal-vs-Social Drinker
1.416590E-01
Non Drinker-vs-Daily Drinker
8.604400E-01
Non Drinker-vs-Weekly Drinker
6.816000E-01
Non Drinker-vs-Occasional Drinker
4.415900E-02
Non Drinker-vs-Social Drinker
6.924100E-02
Daily Drinker-vs-Weekly Drinker
6.005400E-01
Daily Drinker-vs-Occasional Drinker
4.233500E-02
Daily Drinker-vs-Social Drinker
5.302300E-02
Weekly Drinker-vs-Occasional Drinker
1.413230E-01
Weekly Drinker-vs-Social Drinker
2.681200E-01
Occasional Drinker-vs-Social Drinker
4.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.763590E-01
Normal-vs-Grade 2
4.716100E-02
Normal-vs-Grade 3
5.274300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.733600E-01
Grade 1-vs-Grade 3
5.274000E-01
Grade 1-vs-Grade 4
1.763590E-01
Grade 2-vs-Grade 3
6.793800E-01
Grade 2-vs-Grade 4
4.716100E-02
Grade 3-vs-Grade 4
5.274300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.428100E-02
Normal-vs-NonDiabetic
4.057700E-02
Diabetic-vs-NonDiabetic
2.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.635700E-04
Normal-vs-NoPancreatitis
5.222300E-02
Pancreatitis-vs-NoPancreatitis
2.420500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.783840E-01
Normal-vs-N1
1.528370E-02
N0-vs-N1
4.447600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.488100E-02
Normal-vs-TP53-NonMutant
3.020800E-01
TP53-Mutant-vs-TP53-NonMutant
7.709800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
